| Literature DB >> 35333977 |
Aditya Mittal1,2, Akanksha Chauhan3.
Abstract
Biological membrane remodeling is central to living systems. In spite of serving as "containers" of whole-living systems and functioning as dynamic compartments within living systems, biological membranes still find a "blue collar" treatment compared to the "white collar" nucleic acids and proteins in biology. This may be attributable to the fact that scientific literature on biological membrane remodeling is only 50 years old compared to ~ 150 years of literature on proteins and a little less than 100 years on nucleic acids. However, recently, evidence for symbiotic origins of eukaryotic cells from data only on biological membranes was reported. This, coupled with appreciation of reproducible amphiphilic self-assemblies in aqueous environments (mimicking replication), has already initiated discussions on origins of life beyond nucleic acids and proteins. This work presents a comprehensive compilation and meta-analyses of data on self-assembly and vesicular transformations in biological membranes-starting from model membranes to establishment of Influenza Hemagglutinin-mediated membrane fusion as a prototypical remodeling system to a thorough comparison between enveloped mammalian viruses and cellular vesicles. We show that viral membrane fusion proteins, in addition to obeying "stoichiometry-driven protein folding", have tighter compositional constraints on their amino acid occurrences than general-structured proteins, regardless of type/class. From the perspective of vesicular assemblies and biological membrane remodeling (with and without proteins) we find that cellular vesicles are quite different from viruses. Finally, we propose that in addition to pre-existing thermodynamic frameworks, kinetic considerations in de novo formation of metastable membrane structures with available "third-party" constituents (including proteins) were not only crucial for origins of life but also continue to offer morphological replication and/or functional mechanisms in modern life forms, independent of the central dogma.Entities:
Keywords: Influenza; Liposomes; Membrane fusion; Origin of life; Vesicles; Virus
Mesh:
Substances:
Year: 2022 PMID: 35333977 PMCID: PMC8951669 DOI: 10.1007/s00232-022-00230-4
Source DB: PubMed Journal: J Membr Biol ISSN: 0022-2631 Impact factor: 1.843
Protein-free vesicles
| Dia (nm) | Constituents | Primary observation(s) | Reference(s) |
|---|---|---|---|
| 22, 100–1000 | Lecithin, Ovolecithin, Lysolecithin, Chol, K-phosphotungstate | Membranous formations—rings with helical structures, rod-like micelles, vesicles, MLVs, bilayers with varying thickness | Bangham and Horne ( |
| > 1000 | Ovolecithin:Chol:dicetyl-Phosphoric acid (75:10:15) | Uni- and multi-lamellar assemblies, “functional” implications pertaining to membrane permeability | Bangham et al. ( |
| > 1000 | DMPC, DPPC, DSPC, DPPE | Melting temperature (Tm)-dependent phase separation—So and Lα phases in binary mixtures | Shimshick and McConnell ( |
| ~ 200, ~ 460, 100–300, 200–500, 200–1000 | DPPC, PC, PG, PS, Chol | LUVs and oligolamellar vesicles with large internal aqueous volumes encapsulating variety of water-soluble molecules with high efficiencies | Szoka and Papahadjopoulos ( |
| 100–1000 | PC:PA (98:2) | Proton-hydroxyl permeability measurements | Nichols et al. ( |
| 22–25, 100 | PS | Ca2+-induced aggregation and fusion of SUVs and LUVs, content mixing assay | Wilschut et al. ( |
| ~ 230 | Egg yolk PC, Octyl glucoside (detergent) | Unilamellar vesicles formation on removal of detergent from mixtures | Cohen et al. ( |
| 15 | PS | Na+-induced aggregation of SUVs, distinction in rates and extent of aggregation (equilibrium) | Bentz and Nir ( |
| ~ 25, ~ 100 | PS | Ca2+-induced aggregation and leaky fusion of SUVs/LUVs, kinetic characterization | Nir et al. ( |
| ~ 30, ~ 100 | PS | Aggregation kinetics, bilayer destabilization, fusion rates induced by Ba2+, Ca2+, Sr2+, Mg2+ | Bentz et al. ( |
| 100–1000 | Egg yolk lecithin, detergent (C12E8) | Effects of detergent removal kinetics on assembly of unilamellar vesicles and their permeability | Ueno et al. ( |
| > 2000 | Asolectin, Ergosterol | Leakage during membrane fusion, adhesive forces promote membrane tension and rupture | Niles and Cohen ( |
| 10–50 | DMPC, DPPC | Thermodynamically spontaneous fusion of SUVs to form intermediate-sized unilamellar vesicles | Lentz et al. ( |
| 200, 100–1000 | DOPC, DOPE, | LUVs, MLVs, SUVs, Lα to HII phase transitions in membrane fusion (with inverted micelle intermediates, interlamellar attachments) | Ellens et al. ( |
| > 1000 | PC (lecithin), DPPC, β-arachidonoyl γ-palmitoyl-PC | Fast (< 2 min) assembly of GUVs, “Cell-sized” proteoliposomal assembly | Moscho et al. ( |
| > 1000 | DOPC, Chol | Estimation of line tension, effects of differently shaped inclusion molecules in membranes | Karatekin et al. ( |
| > 1000 | DOPC, SM, Chol | Lo/Ld phase separations, morphologically distinct assemblies | Baumgart et al. ( |
| > 1000 | O-ethyl-PC, DOPC, DOPG (glycerol) | Vesicle fusion by video fluorescence microscopy | Lei and MacDonald ( |
| > 1000 | DOPC, DPPC, POPC, Chol (Binary/Ternary mixtures) | Phase diagrams, temperature-dependent domain ripening and curvatures | Veatch et al. ( |
| > 1000 | DOPC, POPC, palmito-SM, Chol | Miscibility phase diagrams, coexistence of Lo/Lα, and formation of So at different temperatures | Veatch and Keller ( |
| > 1000 | DOPC, DPPC, Sterols | Sterol-specific assemblies with and without coexisting phases (So/Liquid) | Beattie et al. ( |
| 200–300 | Bacterial—PE | Liposomal assemblies from bacterial lipids | Gupta et al. ( |
| 50, 100–400 | “Prebiotic” mixtures of decanoic (capric), lauric, oleic, and octanoic acids | Glycerol monoacyl amphiphiles stabilize “assemblies”; leaky “vesicles,” mixing of “membranes” at “high” temperatures | Maurer et al. ( |
| 200–400 | DOPE:DOPC:Chol | Critical “Compartmentalization” Concentration of stoichiometrically defined compositions | Mittal and Grover ( |
| 150–200 | CTAB, Chol, DOPC | Vesicle preparations using a compressed fluid-based method are more homogeneous | Elizondo et al. ( |
| > 1 µm | DOPC:DOPG (8:2) | “Electroformation” of vesicles, transient asymmetry and morphological transitions | Steinkühler et al. ( |
| > 1 µm | l-α-PC (Soy), DOPE, Bacterial—CL, PE, PG | Ca2+-dependent vesicle and “subcompartment” formation from surfaces by interfacial events | Spustova et al. ( |
Lipids→Chol Cholestrol, CL Cardiolipin, CTAB Cetrimonium bromide, DM Dimyristoyl, DO Dioleoyl, DP Dipalmitoyl, DS Distearoyl, PA Phosphatidic acid, PC Phosphatidylcholine, PE Phosphatidylethanolamine, PG Phosphatidylglycerol, PS Phosphatidylserine, SM Sphingomyelin, Others→Dia Diameter, Phases (H Hexagonal, Lα Liquid crystalline, Lo Liquid ordered, Ld Liquid disordered, So Solid), Tm Melting temperature, GUV Giant unilamellar vesicle, LUV Large Unilamellar vesicle, SUV Small unilamellar vesicle, MLV Multilamellar vesicle
Fig. 1Timeline from advent of liposomes to development of experimental systems and assays for membrane assemblies and fusion (see text for details). The timeline captures some of the key original experimental advances—from the first liposomes in the 1960s, to the latest protein-free vesicular assemblies involving “electroformation” of GUVs from heterogenous SUVs (Bhatia et al. 2015) along with inducing of transient bilayer asymmetries by varying intra- and extra- vesicular conditions (Bhatia et al. 2018, 2020). Here, it is pertinent to enforce the importance of properly interpreting the hydrophobic effect—the term “hydrophobic interaction” neither implies any force nor is it a real “interaction”—it is actually exclusion by water. In absence of an aqueous environment, “hydrophobic” molecular entities do not show any tendency to interact with each other. Thus, while the word “hydrophobic” may appear to imply phobia from water, experimentally and scientifically it represents only exclusion from/by liquid water (anecdotally interpretable as water’s phobia for such molecules/entities rather than the other way around). The figure is drawn only for illustration purposes and not to any scale
Fig. 2Timeline for establishment of Influenza HA as a prototypical membrane fusion protein and development of experimental assays for studying HA-mediated membrane fusion (see text for details). Wilson et al. (1981) solved the structure of bromelain-cleaved HA (called BHA) at neutral pH—the first structure shown is from PDB (Berman et al. 2000) PDB ID: 5HMG (Wilson et al. 1981; Weis et al. 1990); the second structure, called TBHA2, shown is PDB ID: 1HTM (Bullough et al. 1994) which is trypsin + thermolysin + bromelain—cleaved HA at low pH. Overall interpretation from 5HMG and 1HTM is that HA is a trimer with each monomer having two subunits—HA1 responsible for receptor binding and HA2 responsible for membrane fusion. The figure is drawn only for illustration purposes and not to any scale
Enveloped mammalian viruses
| Name | Family | Shape | Size (nm) | VMP(Su) | Reference(s) |
|---|---|---|---|---|---|
| Influenza Virus | ~ Spherical, Pleomorphic | 80–120 | HA (HA1/HA2) | Elford et al. ( | |
| FIV | Filamentous | Len 250–30,000; Dia ~ 80 | HA (HA1/HA2) | Ada and Perry ( | |
| NCDV | Pleomorphic | 200–300 | HN, F | Silverstein and Marcus ( | |
| HPIV | Pleomorphic | 150–250 | F, HN | Howe et al. ( | |
| SendaiV | Pleomorphic | 150–200 | HN, F(F1/F2) | Scheid and Choppin ( | |
| Measles Virus | Pleomorphic, ~ Spherical | 120–250 | H, F | Wild et al. ( | |
| EIAV | Pleomorphic, ~ Spherical | 80–120 | Env | Tajima et al. ( | |
| HIV(T1) | ~ Round | ~ 120 | Env (gp160/120/gp41) | Chan et al. ( | |
| VSV | ~ Cylindrical | L ~ 190, D ~ 85 | VSV-G | Kelley et al. ( | |
| Rabies Virus | ~ Cylindrical | L ~ 180, D ~ 75 | G | Anilionis et al. ( | |
| HSV 1 | IC, “Spikey” Envelope | ~ 225 | gB, gC, gD, gH/L | Sarimento et al. ( | |
| EBV | Pleomorphic | ~ 150–200 | gH-gL-gp42 complex, gp350/220 | Nemerow et al. ( | |
| CMV | Spherical, Pleomorphic | 150–200 | gB, gH, gM, gL | Landolfo et al. ( | |
| SFV | ~ Spherical | 70 | E1, E2, E3 | Garoff et al. ( | |
| SinV | ~ Spherical | ~ 60 | E1, E2 | Dalrymple ( | |
| HBV | Spherical | 42 | HBsAg (S, M, L) | Pasek et al. ( | |
| RSV A | Spherical, Filamentous | ~ 150 | G, F, SH | Mufson et al. ( | |
| TBE V | IPC*, ~ Spherical | ~ 50 | E, prM (pr/M) | Chambers et al. ( | |
| DenV | IPC*, ~ Spherical | ~ 50 | E | Chen et al. ( | |
| WNV | IPC*, ~ Spherical | ~ 50 | E, M | Mukhopadhyay et al. ( | |
| HCV | IPC*, ~ Spherical | ~ 50 | E1, E2 | Yu et al. ( | |
| ZikaV | IPC*, ~ Spherical | ~ 50 | E, M | Sirohi et al. ( | |
| OHV | Spherical/Oval | 90–120 | GN, GC | Antic et al. ( | |
| VV | Brick shaped | ~ 360 × 270 × 250 | P16, P8 | Salmons et al. ( | |
| EbolaV | ~ Cylindrical, Pleomorphic | L ≥ 900, D ~ 80 | GP (GP1/GP2) | Volchkov ( | |
| HCoV | ~ Spherical | 60–140 | S (S1/S2) | Bosch et al. ( | |
| MERS- CoV | ~ Spherical | 75–105 | S(S1/S2) | Wang et al. ( | |
| SARS-CoV-2 | ~ Spherical | 60–140 | S (S1/S2) | Zhu et al. ( | |
| LFV | Round/Oval, Pleomorphic | 100–130 | GP (GP1/GP2) | Günther and Lenz ( | |
| Mimivirus | IC-Inner membrane | 400–800 | GlyFP, MCP* | Xiao et al. ( | |
| ASFV | Icosahedral, Internal envelope | 175–215 | CD2v | Dixon and Chapman ( | |
| TFV* | Hexagonal/Round | 100–200 | ORF001L, ORF020R | Wang et al. ( |
ASFV African Swine Fever Virus, DenV Dengue Virus, EbolaV Ebola Virus, EBV Epstein–Barr Virus, EIAV Equine Infectious Anemia Virus, FIV Filamentous Influenza Virus, GlyFP, MCP* Glycosylated Fibrous Proteins, Major Capsid Protein covering an inner viral membrane (host binding, viral fusion activities not yet reported), HBV Hepatitis B Virus, HCoV Human Corona Virus, HCV Hepatitis C Virus, HIV(T1) Human Immunodeficiency Virus (Type 1), HPIV Human Parainfluenza Virus, HSV 1 Herpes Simplex Virus 1, IC Icosahedral Capsid, LFV Lassa Fever Virus, MERS CoV-Middle East Respiratory Syndrome Corona Virus, NCDV NewCastle Disease Virus, OHV OrthoHantaVirus, IPC* Icosahedral Protein Coat, RSV A Respiratory Syncytial Virus, SARS-Cov-2 Severe Acute Respiratory Syndrome Corona Virus2, SendaiV Sendai Virus, SFV Semliki Forest Virus, SinV Sindbis Virus, TBE V Tick-Borne Encephalitis Virus, TFV* Tiger Frog Virus (not a mammalian virus, however is studied in a human liver cancer cell line HepG2, VMPs are putative) , VSV Vesicular Stomatitis Virus, V Virus, VV Vaccinia Virus, WNV West Nile Virus, CMV Cytomegalovirus, VMP(Su) Viral Membrane Protein (Subunits)
Fig. 3Stoichiometric distributions of amino acids in viral fusion proteins (VMPs). These are compared with “structured” (open bars, n = 27,199), “sequences without structure” (gray bars, n = 532,553), “curated/reviewed intrinsically disordered proteins” (black-striped bars, n = 707), and “putative intrinsically disordered proteins” (gray-striped bars, n = 94)→for data and details, see Mittal et al. (2021c). The following sequences of fusogenic (components of) VMPs were collected from UniProtKB—HA2 (HA2-X31: P03437, HA2-Jap: P03451, HA2-PR8: P03452) and other viral fusion proteins (HIV1-gp41: P03375, HIV1-gp41: P03378, HIV2-gp41: P15831, HIV2-gp41: P20872, SFV-E1: Q8JMP5, Sin-E1:P03316, Sin-E1: P27285, TBE-E: P07720, TBE-E: P14336, TBE-E: Q01299, Den1-E: P27910, Den2-E: P29990). Yellow bars represent stoichiometric distributions of only HA2 (n = 3) and black bars represent stoichiometric distributions of all VMPs (n = 15)
Extracellular vesicles
| Name | Size (nm) | Cellular source(s) | Reference(s) |
|---|---|---|---|
| Ectosome (or microparticle/microvesicle/shedding vesicle) | 50–200 | Assembled and released from plasma membrane. (Neutrophils, macrophages, microglia, weaker expulsion of microparticles from other, possibly all, cell types) | Simpson et al. ( |
| Microparticles | 100–1000 | Plasma membrane of most cell types | Simpson et al. ( |
| Microvesicles | 20–1000 | Plasma membrane of most cell types | Simpson et al. ( |
| Exosome | 30–200 | Exocytosis of multivesicular bodies (MVBs), rarely by plasma membrane budding | Pap et al. ( |
| Exosome-like vesicles | 80–200 | MCF-7, MDA-MB 231 cells (breast cancer) | Kruger et al. ( |
| Dexosome | ~ 130 (50–400) | Exosomes released from dendritic cells | Näslund et al. ( |
| Argosome | Not reported | Lipoprotein particles enriched with GPI-linked proteins (exogenously derived or from plasma membranes), basolateral membranes of “Wingless-producing cells” in Drosophila | Greco et al. ( |
| Epididymosome | 50–250 | Epididymal fluid | Sullivan ( |
| Tolerosome | ~ 40 | Intestinal epithelial cells | Karlsson et al. ( |
| Oncosome | 100–400 and sometimes larger | Tumor cell membranes | Van der Pol et al. ( Meehan et al. ( |
| Large oncosome | > 1000–> 10,000 nm | Large protrusions from/on cancer cell membranes | Di Vizio et al. ( |
| Prominosomes (P2, P4) | ~ 600 (P2), 50–80 (P4) | Ventricular fluid in developing embryonic mouse brain P4, also in human colon carcinoma cells (Caco-2) and body fluids (saliva, urine, seminal fluid) | Simpson et al. ( |
| Prostasomes | 50–500 | Prostate epithelial cells or seminal fluid | Simpson et al. ( |
| Outer membrane vesicles | 20–250 | Secretory vesicles of Gram-negative bacteria | Simpson et al. ( |
Intracellular vesicles
| Name | Size (nm) | Cellular source(s) | Reference(s) |
|---|---|---|---|
| Clathrin-coated vesicle | ~ 50, ~ 70, 100–120 | Bud from plasma membrane and trans-Golgi network | Roth et al. ( |
| COPI-coated vesicle | ~ 75 (50–100) | Golgi-derived coated vesicle | Orci et al. ( |
| COPI-coated vesicle | 60–100 | Bud from Endoplasmic Reticulum | Barlowe et al. ( |
| Caveolar endocytic vesicle | 65–90, ~ 100 | Plasmalemmal | Peters et al. ( |
| Macropinosome | 200–10,000 | Plasma membrane, actin skeleton | Swanson ( |
| Phagosome | > 500 | Plasma membrane, actin skeleton (phagocytic cells) | Swanson ( |
| Endosome | ~ 400 (Early) ~ 760 (Late) | In-budding of the plasma membrane | Ganley et al. ( |
| Lysosome | 100–1200 | Multi-vesicular from Endoplasm maturation in most eukaryotic cells | Lübke et al. ( |
| Vacuole | Large, variable | Cytoplasm of plants, protists, yeasts, and some animal cells | Matile ( |
| Peroxisome | 100–1000 | Eukaryotic cytoplasm (multiple possibilities—de novo, from ER or other peroxisomes) | Tuller et al. ( |
| Apoptotic vesicle | 50–5000 | ER and plasma membrane in most cells | Mallat et al. ( |
| Secretory vesicle | 90–1000 | Budding off from Golgi network | Surma et al. ( |
| Dense core vesicle/granule | ~ 70 | Kim et al. ( | |
| Large dense core vesicle (synaptic) | ~ 90 | Walch-Solimena et al. ( | |
| Small synaptic vesicle | ~ 50 | Simpson et al. ( | |
| Secretory lysosome | ~ 700 with smaller (40–70) internal vesicles | Diverse structures (dense cores, multilaminar, unique structures) from Endoplasm maturation (in some melanocytes, cells from hematopoietic lineage, renal tubular cells) | Blott and Griffiths ( |
Fig. 4Theory on origins of life and biological replication independent of central dogma. A De novo appearance of a micelle and “replication” of the micelle based on law of mass action—a proposal on origins of life and evolution of biological systems from a world of biological membranes (see Mittal et al. 2020 for details). B Unilamellar compartments with bilayer formations from similar lipids, binary mixtures, and a heterogenous systems with lipids “third-party” components. C Free energy diagrams for hypothetical systems shown in A (red) and B (black). The arrows represent kinetic windows during thermodynamic transitions toward stabilization of membrane formations above the possible lowest energy states. The free energy curves also represent relative free energies of respective panels in A and B. The figure is drawn only for illustrative purposes and is not to any scale